Working memory training to improve fear extinction in veterans with PTSD

Identifying Clinically Relevant Neural Circuit Mechanisms of Cognitive Control Training for PTSD

Not applicable Interventional VA Office of Research and Development · NCT06629064

This study is testing if a special memory training program can help veterans with PTSD learn to manage their fears better.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment120 (estimated)
Ages18 Years to 65 Years
SexAll
SponsorVA Office of Research and Development Federal
Locations1 site (San Diego, California)
Trial IDNCT06629064 on ClinicalTrials.gov

What this trial studies

This study tests whether a working memory training (WMT) program can enhance fear extinction learning and its neural mechanisms in veterans diagnosed with posttraumatic stress disorder (PTSD). The approach involves conducting eight remote training sessions over four weeks, alongside MRI scans to assess changes in brain activity. By linking working memory capabilities to fear extinction, the study aims to provide insights that could improve existing PTSD treatments, particularly exposure therapy. The research supports the Department of Veteran Affairs' mission to develop effective treatment strategies for veterans suffering from PTSD.

Who should consider this trial

Good fit: Ideal candidates for this study are veterans who meet DSM-5 criteria for PTSD and are fluent in English.

Not a fit: Patients with a history of severe mental health disorders, acute suicidality, or significant neurological issues may not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could significantly improve treatment outcomes for veterans with PTSD by enhancing their ability to process and overcome traumatic memories.

How similar studies have performed: Previous studies have shown that working memory training can positively influence fear extinction in civilian populations, suggesting potential for success in this veteran-focused approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Fluent in English
* Meet current DSM-5 criteria for Posttraumatic Stress Disorder
* Are willing to attend 8 total remote sessions of working memory training over course of four weeks
* Are willing to attend MRI scans pre and post working memory training
* 4-week stability on pharmacological and psychosocial treatments

Exclusion Criteria:

* A lifetime history of psychotic disorders, lifetime history of bipolar disorder
* Past-year severe substance use and severe alcohol use disorder. Mild-to-moderate alcohol use disorder will be allowed to enhance generalizability in our sample due to the high comorbidity of alcohol use and PTSD
* History of any neurological disorder that might be associated with cognitive dysfunction (e.g., cerebrovascular accident, intracranial surgery, aneurysm, seizure disorder)
* Acute suicidality requiring immediate clinical intervention
* Moderate to severe traumatic brain injury (TBI). However, mild to moderate levels of TBI (mTBI) will be included.
* Receiving benzodiazepines or medications with anticholinergic effects that may affect fear learning measures
* Inability to safely complete fMRI session (i.e., metal in body, medical implants)

Where this trial is running

San Diego, California

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Post-Traumatic Stress DisordersStress Disorders, TraumaticPost Traumatic Stress DisorderPTSDTrauma and Stressor Related Disorderscognitive trainingworking memoryFear Extinction
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.